NeoGenomics Expands Indica Labs Partnership to Scale AI-Powered Digital PathologyBusiness Wire • 10/15/26
NeoGenomics to Report Third Quarter 2026 Financial Results on October 28, 2026Business Wire • 10/14/26
Stryker, Neogenomics Announce CEO Transitions; But One Stock DivesInvestors Business Daily • 10/06/26
NeoGenomics Announces Executive Leadership and Board of Directors Succession PlanBusiness Wire • 10/05/26
NeoGenomics, Inc. (NEO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/15/26
NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare ConferenceBusiness Wire • 09/01/26
NeoGenomics Receives Medicare Coverage for RaDaR ST for Immunotherapy Treatment Response MonitoringBusiness Wire • 08/26/26
NeoGenomics, Inc. (NEO) Hit a 52 Week High, Can the Run Continue?Zacks Investment Research • 08/04/26
NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate CancerBusiness Wire • 07/09/26
NeoGenomics (NEO) Soars 7.2%: Is Further Upside Left in the Stock?Zacks Investment Research • 06/19/26
NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior NotesBusiness Wire • 06/17/26